Newsroom

Sorted by: Latest

-

WhiteHawk Minerals Announces Pricing of Upsized Initial Public Offering

PHILADELPHIA--(BUSINESS WIRE)--WhiteHawk Income Corporation (“WhiteHawk Minerals” or the “Company”) today announced the pricing of the upsized initial public offering of 7,700,000 shares of its Class A common stock at a price to the public of $26.00 per share. The 7,700,000 share offering represents a 775,000 share upsize to the originally proposed 6,925,000 share offering. The Company has granted the underwriters a 30-day option to purchase up to an additional 1,155,000 shares of its Class A c...
-

Datos clínicos revolucionarios de Diabetology sobre Oraglutide™ GLP-1 oral

NUEVA ORLEANS--(BUSINESS WIRE)--Presentación de Diabetology Limited (Jersey) de póster 1724-P (https://diabetology.co.uk/ada-poster) en la 86.ª Sesión Científica de la American Diabetes Association (ADA), celebrada en Nueva Orleans, con los primeros datos en humanos de Oraglutide™, una semaglutida oral de liberación intestinal en cápsulas pequeñas, formulada con la tecnología de administración patentada Axcess™. ASPECTOS DESTACADOS Control de glucosa durante 6 días: una dosis oral única de 4 mg...
-

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against GeneDx Holdings Corp. (NasdaqGS: WGS) (“GeneDx” or the “Company”), if they purchased or otherwise acquired the Company’s shares between April 16, 2025 and May 4, 2026, inclusive (the “Clas...
-

Riassunto: Resident Evil Veronica debutterà nel 2027!

OSAKA, Giappone--(BUSINESS WIRE)--Capcom Co., Ltd. (TOKYO:9697) oggi ha annunciato che il lancio di Resident Evil Veronica, l'ultimo titolo nella serie Resident Evil, è previsto per il 2027. La saga Resident Evil comprende giochi di sopravvivenza in contesti di orrore, nei quali i giocatori si servono di una varietà di armi e altri oggetti per sopravvivere in situazioni terrificanti. Grazie a una base di appassionati giocatori a livello globale, le vendite complessive dei giochi fin dal primo t...
-

INVESTOR ALERT: Securities Class Action Filed Against Verra Mobility Corporation – Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Verra Mobility Corporation (“Verra Mobility” or the “Company”) (NASDAQ:VRRM) securities during the period of February 24, 2026 through May 26, 2026, inclusive (“the Class Period”).If you suffered a loss on your Verra Mobility investments, you have until August 4, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff ap...
-

PointsBet Goes All In on Grafana Cloud to Power AI-Driven Observability at Scale

SYDNEY--(BUSINESS WIRE)--Grafana Labs, the company behind the open observability cloud, today announced that PointsBet, one of Australia’s fastest-growing digital wagering operators, has selected Grafana Cloud as its unified observability platform. PointsBet is using Grafana Cloud to consolidate telemetry across its proprietary betting platform, accelerate incident resolution with AI-powered insights, and give engineering teams the visibility they need to own and operate their services with con...
-

Diabetology veröffentlicht bahnbrechende klinische Daten zu dem oralen GLP-1-Präparat Oraglutide™

NEW ORLEANS--(BUSINESS WIRE)--Posterpräsentation von Diabetology Limited (Jersey) (https://diabetology.co.uk/ada-poster) 1724-P im Rahmen der 86. ADA-Wissenschaftstagung in New Orleans, in der erste Daten aus Humanstudien zu Oraglutide™ vorgestellt wurden — einem in kleinen Kapseln verabreichten, im Darm freigesetzten oralen Semaglutid, das unter Verwendung der firmeneigenen Axcess™-Verabreichungstechnologie entwickelt wurde. DIE WICHTIGSTEN HIGHLIGHTS 6-Tage-Glukosekontrolle: Eine einmalige or...
-

INVESTOR ALERT: Securities Class Action Filed Against PicS N.V. – Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired PicS N.V. (“PicS” or the “Company”) (NASDAQ:PICS) securities during the period from January 27, 2026 through June 5, 2026. If you suffered a loss on your PicS investments, you have until August 4, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications submitted after this deadline. If you choose to take no...
-

Resumen: ¡Resident Evil Veronica se lanzará en 2027!

OSAKA, Japón--(BUSINESS WIRE)--Capcom Co., Ltd. (TOKYO:9697) anunció hoy que Resident Evil Veronica, el juego más reciente de la serie Resident Evil, tiene fecha de lanzamiento prevista para 2027. La franquicia Resident Evil incluye juegos de terror de supervivencia donde los jugadores utilizan una serie de armas y otros objetos para sobrevivir en situaciones aterradoras. Con el apoyo de una base de fanáticos global apasionada, las ventas de juegos totales desde el primer lanzamiento de esta se...
-

Données cliniques révolutionnaires de Diabetology sur l’Oraglutide™, un GLP-1 oral

NOUVELLE-ORLÉANS--(BUSINESS WIRE)--Présentation par affiche de Diabetology Limited (Jersey) (https://diabetology.co.uk/ada-poster) 1724-P lors de la 86e session scientifique de l’ADA, à La Nouvelle-Orléans, rendant compte des premières données humaines sur l’Oraglutide™, une petite capsule de séma-glutide oral à libération intestinale, formulée à l’aide de la technologie de délivrance exclusive Axcess™. POINTS CLÉS Contrôle glycémique sur 6 jours : une dose orale unique de 4 mg d’Oraglutide™ a...